BioSpace News Archive

Press Releases

Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC

May 20, 2025
·
4 min read
Press Releases

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

May 20, 2025
·
5 min read
Press Releases

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

May 20, 2025
·
8 min read
Press Releases

Solmetex(R) Introduces NEW Sterisil(R) R2A with FASTRead(TM)

May 20, 2025
·
2 min read
Press Releases

New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection

May 20, 2025
·
3 min read
Press Releases

Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities

May 20, 2025
·
6 min read
Press Releases

Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)

May 20, 2025
·
8 min read
Press Releases

Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM

May 20, 2025
·
12 min read
Press Releases

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

May 20, 2025
·
4 min read
Press Releases

Aptose Announces Dosing of First Patient with 120 mg of Tuspetinib in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy after Dose Escalation Decision by Safety Review Committee

May 20, 2025
·
6 min read